SCHEMBL6712433

SCHEMBL6712433

CCCC(=O)Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3noc(=O)[nH]3)[nH]c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.42
PLCG2 P16885 1/20 0.40
PLA2G7 Q13093 3/20 0.39
POLB P06746 3/20 0.38
GAA P10253 1/20 0.38
PARP14 Q460N5 1/20 0.38
ALDH1A1 P00352 1/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.37
TP53 P04637 1/20 0.37
PTK2B Q14289 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
NHERF1 O14745 1/20 0.36
F2R P25116 1/20 0.36
CMKLR1 Q99788 1/20 0.36
ADORA1 P30542 1/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713462 0.95 HDAC3 (0.41) GRIK1PLCG2PLA2G7POLBALDH1A1
SCHEMBL6710607 0.95 GRIK1 (0.41) GRIK1PLCG2PLA2G7POLBALDH1A1
SCHEMBL6710059 0.94 HDAC3 (0.42) GRIK1PLCG2PLA2G7POLBALDH1A1
SCHEMBL6756845 0.94 HDAC3 (0.42) GRIK1PLCG2PLA2G7POLBALDH1A1
SCHEMBL6709877 0.93 GRIK1 (0.43) GRIK1PLCG2PLA2G7POLBALDH1A1
SCHEMBL6711957 0.90 GRIK1 (0.40) GRIK1PLA2G7POLBPARP14ALDH1A1
SCHEMBL6712543 0.90 GRIK1 (0.43) GRIK1PLCG2PLA2G7POLBLMNA
SCHEMBL6714306 0.90 HDAC3 (0.40) GRIK1PLCG2PLA2G7POLBLMNA
SCHEMBL6708940 0.90 ALOX15 (0.44) GRIK1PLCG2ALDH1A1HDAC3HDAC1
SCHEMBL6710045 0.90 MEN1 (0.44) GRIK1PLCG2PLA2G7POLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885PLCG2 4289/4885PLA2G7 3314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.